CoAxia Inc.

CoAxia Inc. has a new approach to neuroprotection for ischemic stroke: by partially restricting blood flow in the lower body, it diverts a larger portion of cardiac output into the cerebral vasculature to perfuse the penumbra, keeping those cells viable until circulation is restored. CoAxia believes its technology is simple, safe, and will dramatically expand the treatment window for ischemic stroke patients.

More from Archive

More from Medtech Insight